To Accelerate Development of Rare, Ultra-Rare, and Orphan Drug Programs To Reach Patients in Need
At GeneScape we envision a world where people with rare, ultra-rare, and orphan genetic diseases have options for treatment and potential cures. Clinical research is often complex and challenging; but we believe that with a clear view of the unmet need for specific indications we can support sustainable development of innovative therapies.
Illustrating the Most Up-To-Date Picture of Your
Target Patient Population
The GeneScape information technology platform was developed to accurately fill in the knowledge gaps in patient estimates and demographics for rare, ultra-rare and orphan diseases to support development of innovative therapies. We focus on defining the scale of unmet need, uncovering patient segments and where best to find them.
How We Work
Dedicated to Providing Robust Modelling for Data-Driven
Our team has deep expertise in genetics, pathology, drug development, and informatics. We leverage our integrated genomics platform, focusing on data quality, bio-curation, and rapid adoption of the latest tools to bring you actionable data to support your drug development strategy.
GeneScape is a remote-first/hybrid company based in the Netherlands.